naltrexone has been researched along with neuropeptide y in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (43.75) | 18.2507 |
| 2000's | 6 (37.50) | 29.6817 |
| 2010's | 2 (12.50) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Billington, CJ; Briggs, J; Grace, MK; Kotz, CM; Levine, AS | 1 |
| al-Dokhayel, AA; Bloom, SR; Gilbey, SG; Lambert, PD; Wilding, JP | 1 |
| al-Dokhayel, AA; Bloom, SR; Bohuon, C; Comoy, E; Gilbey, SG; Lambert, PD; Wilding, JP | 1 |
| Billington, CJ; Grace, MK; Kotz, CM; Levine, AS | 1 |
| Billington, CJ; Briggs, JE; Grace, MK; Kotz, CM; Levine, AS | 2 |
| Billington, CJ; Kotz, CM; Levine, AS | 1 |
| Billington, CJ; Glass, MJ; Kotz, CM; Levine, AS | 1 |
| Billington, CJ; Grace, MK; Jewett, DC; Jones, RM; Levine, AS; Portoghese, PS | 1 |
| Li, JJ; Li, Y; Yu, LC | 1 |
| Gallate, JE; McGregor, IS | 1 |
| Egli, M; Heilig, M | 1 |
| Gaburro, S; Herzog, H; Rosskothen, I; Schunk, E; Schwarzer, C; Singewald, N; Wittmann, W | 1 |
| Brunetti, L; Chiavaroli, A; Di Nisio, C; Ferrante, C; Leone, S; Manippa, F; Mollica, A; Orlando, G; Recinella, L; Ricciuti, A; Shohreh, R; Vacca, M | 1 |
| Cicin-Šain, L; Kovak-Mufić, A; Marušić, S; Matošić, A; Vidrih, B | 1 |
| Brunton, C; Carroll, RM; Ewan, EE; Grace, MK; Hahn, TW; Head, MA; Jewett, DC; Klockars, A; Kwilasz, AJ; Levine, AS; Olszewski, PK; Smith, TR; Tham, RL; Wiebelhaus, JM | 1 |
2 review(s) available for naltrexone and neuropeptide y
| Article | Year |
|---|---|
Pharmacological treatment of alcohol dependence: target symptoms and target mechanisms.
Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Animals; Baclofen; Corticotropin-Releasing Hormone; Disease Models, Animal; Disulfiram; Fructose; Humans; Naltrexone; Neuropeptide Y; Nociceptin; Ondansetron; Opioid Peptides; Receptor, Cannabinoid, CB1; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Taurine; Topiramate | 2006 |
NEUROBIOLOGICAL BASES OF ALCOHOL ADDICTION.
Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Brain; Disulfiram; Dopamine; gamma-Aminobutyric Acid; Glutamic Acid; Humans; Minisatellite Repeats; Monoamine Oxidase; Naltrexone; Narcotic Antagonists; Neuropeptide Y; Norepinephrine; Ondansetron; Polymorphism, Genetic; Serotonin; Synaptic Transmission; Taurine | 2016 |
14 other study(ies) available for naltrexone and neuropeptide y
| Article | Year |
|---|---|
Effects of opioid antagonists naloxone and naltrexone on neuropeptide Y-induced feeding and brown fat thermogenesis in the rat. Neural site of action.
Topics: Adipose Tissue, Brown; Animals; Brain; Energy Metabolism; Feeding Behavior; Male; Naloxone; Naltrexone; Neuropeptide Y; Obesity; Paraventricular Hypothalamic Nucleus; Rats; Rats, Sprague-Dawley; Solitary Nucleus | 1995 |
The effect of central blockade of kappa-opioid receptors on neuropeptide Y-induced feeding in the rat.
Topics: Animals; Cerebral Ventricles; Drug Administration Schedule; Dynorphins; Feeding Behavior; Injections, Intraventricular; Male; Naltrexone; Neuropeptide Y; Rats; Rats, Wistar; Receptors, Opioid, kappa | 1993 |
A role for neuropeptide-Y, dynorphin, and noradrenaline in the central control of food intake after food deprivation.
Topics: Animals; Antibodies, Monoclonal; Dynorphins; Eating; Food Deprivation; Immunization, Passive; Male; Naltrexone; Neuropeptide Y; Norepinephrine; Phentolamine; Rats; Rats, Wistar; Receptors, Opioid, kappa | 1993 |
The effect of norbinaltorphimine, beta-funaltrexamine and naltrindole on NPY-induced feeding.
Topics: Animals; Eating; Injections, Intraventricular; Male; Naltrexone; Narcotic Antagonists; Neuropeptide Y; Rats; Rats, Sprague-Dawley | 1993 |
Naltrexone induces arcuate nucleus neuropeptide Y gene expression in the rat.
Topics: Adipose Tissue, Brown; Animals; Arcuate Nucleus of Hypothalamus; Carrier Proteins; Eating; Food Deprivation; Gene Expression; Ion Channels; Male; Membrane Proteins; Mitochondrial Proteins; Naltrexone; Neuropeptide Y; Rats; Rats, Sprague-Dawley; RNA, Messenger; Uncoupling Protein 1 | 1996 |
Effect of naltrexone on feeding, neuropeptide Y and uncoupling protein gene expression during lactation.
Topics: Animals; Eating; Female; Gene Expression; Lactation; Naltrexone; Neuropeptide Y; Proteins; Rats; Rats, Sprague-Dawley | 1997 |
Divergence of the feeding and thermogenic pathways influenced by NPY in the hypothalamic PVN of the rat.
Topics: Adipose Tissue, Brown; Animals; Body Temperature Regulation; Carrier Proteins; Feeding Behavior; Ion Channels; Lipoprotein Lipase; Male; Membrane Proteins; Microinjections; Mitochondrial Proteins; Naltrexone; Neuropeptide Y; Paraventricular Hypothalamic Nucleus; Rats; Rats, Sprague-Dawley; RNA, Messenger; Solitary Nucleus; Time Factors; Transcription, Genetic; Uncoupling Protein 1 | 1998 |
Regional effect of naltrexone in the nucleus of the solitary tract in blockade of NPY-induced feeding.
Topics: Animals; Dose-Response Relationship, Drug; Eating; Injections; Male; Naltrexone; Narcotic Antagonists; Neuropeptide Y; Rats; Rats, Sprague-Dawley; Rhombencephalon; Solitary Nucleus | 2000 |
The kappa-opioid antagonist GNTI reduces U50,488-, DAMGO-, and deprivation-induced feeding, but not butorphanol- and neuropeptide Y-induced feeding in rats.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics, Non-Narcotic; Analgesics, Opioid; Animals; Brain; Butorphanol; Drug Interactions; Eating; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Food Deprivation; Guanidines; Male; Morphinans; Naltrexone; Narcotic Antagonists; Narcotics; Neuropeptide Y; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa | 2001 |
Anti-nociceptive effect of neuropeptide Y in the nucleus accumbens of rats: an involvement of opioid receptors in the effect.
Topics: Animals; Catheterization; Dose-Response Relationship, Drug; Hot Temperature; Male; Microinjections; Naloxone; Naltrexone; Narcotic Antagonists; Neuropeptide Y; Nucleus Accumbens; Pain Measurement; Peptide Fragments; Physical Stimulation; Rats; Rats, Wistar; Receptors, Neuropeptide Y; Receptors, Opioid | 2002 |
Rats on the grog: novel pharmacotherapies for alcohol craving.
Topics: Alcoholism; Animals; Baclofen; Beer; Behavior, Addictive; Cannabinoid Receptor Antagonists; Corticotropin-Releasing Hormone; Humans; Models, Animal; Naltrexone; Narcotic Antagonists; Neuropeptide Y; Piperidines; Pyrazoles; Rats; Receptors, Corticotropin-Releasing Hormone; Receptors, GABA-B; Research Design; Rimonabant | 2004 |
Prodynorphin-derived peptides are critical modulators of anxiety and regulate neurochemistry and corticosterone.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Amygdala; Animals; Anxiety; Brain Stem; Corticosterone; Corticotropin-Releasing Hormone; Dynorphins; Enkephalins; Exploratory Behavior; Female; Guanidines; Hypothalamus; Male; Maze Learning; Mesencephalon; Mice; Mice, Inbred C57BL; Mice, Knockout; Morphinans; Naltrexone; Neuropeptide Y; Neuropeptides; Protein Precursors; Raphe Nuclei; Receptors, Opioid, kappa; Stress, Psychological | 2009 |
Orexigenic effects of endomorphin-2 (EM-2) related to decreased CRH gene expression and increased dopamine and norepinephrine activity in the hypothalamus.
Topics: Agouti-Related Protein; Animals; Arcuate Nucleus of Hypothalamus; Corticotropin-Releasing Hormone; Dopamine; Feeding Behavior; Gene Expression Regulation; Humans; Hypothalamus; Intracellular Signaling Peptides and Proteins; Naltrexone; Nerve Tissue Proteins; Neuropeptide Y; Neuropeptides; Norepinephrine; Oligopeptides; Orexins; Pro-Opiomelanocortin; Rats; Serotonin | 2013 |
Effects of opioid receptor ligands in rats trained to discriminate 22 from 2 hours of food deprivation suggest a lack of opioid involvement in eating for hunger.
Topics: Analgesics, Opioid; Animals; Behavior, Animal; Conditioning, Operant; Discrimination Learning; Feeding Behavior; Food Deprivation; Hunger; Male; Naltrexone; Narcotic Antagonists; Neuropeptide Y; Rats; Rats, Sprague-Dawley; Reward; Satiation; Time Perception | 2020 |